StockData
ANI Pharmaceuticals Inc logo

ANI Pharmaceuticals Inc (ANIP) stock

ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3046% below fair value
$71.47+1.48 (+2.11%)

Close on Nov 18, 2026Market cap $1.64BP/E 15.2Yield –

ANI Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

ANI Pharmaceuticals's pe ratio was 14.4× on Nov 11, 2026, against 52.1× a year earlier. Over the last 5 years it ranged from 14.4× to 173.7×, with a median of 60.6×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202614.4×−34.0
2025Dec 31, 202548.4×−0.5
2024Oct 31, 202448.9×−57.1
2023Dec 29, 2023106.0×+26.0
2020Apr 30, 202080.0×+34.3
2019Dec 31, 201945.7×−59.3
2018Jan 31, 2018104.9×+4.2
2017Dec 29, 2017100.7×+12.8
2016Dec 30, 201687.9×+72.3
2015Dec 31, 201515.6×–

More ANI Pharmaceuticals figures

See a number that looks wrong?